【美银证券：重申京东健康(06618.HK)“买入”评级 对公司前景持更积极看法】智通财经APP获悉，美银证券发布研报称，重申京东健康(06618.HK)“买入”评级，看好公司高增长动能及AI应用潜力;预期2026年收入及经调整营业利润增长分别达15%及26%，高于于阿里健康(00241.HK)的10%及22%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.